Effect of Helicobacter Pylori Eradication on Gastroesophageal RefIux Disease (GERD)

ConditionGERD
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorAssiut University

About this trial

Evaluate the effect of H.pylori eradication on Gastroesophageal-reflux disease and symptoms improvement

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

All patients diagnosed as GERD clinically and endscopically.

Disqualifiers

NO exclusion criteria

Trial population

All patients diagnosed as GERD clinically and endscopically.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Eradication of Helicobacter pylori after triple therapy

H.pylori eradication will be assessed using the endoscope

Time frame
1\2024 to 12\2024
2

Effect of Helicobacter pylori eradication on Gastroesophageal RefIux disease (GERD) syptomes

Evaluate the effect of H.pylori eradication on Gastroesophageal-reflux disease and correlate with GERD symptoms improvement.

Time frame
1\2024 to 12\2024

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.